Your Molecule Got More Complex. Did Your FIH Dose Strategy? 网络研讨会 Your Molecule Got More Complex. Did Your FIH Dose Strategy? Certara2026 年 8 月 17 日
MBMA data curation: How AI and expert meta-analysts get it right, fast Blog MBMA data curation: How AI and expert meta-analysts get it right, fast In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…Matt Zierhut, PhD MBA2026 年 8 月 14 日
A model-informed approach to radioligand therapy dosing under Project Optimus Blog A model-informed approach to radioligand therapy dosing under Project Optimus Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…Hunter Stephens, PhD2026 年 8 月 13 日
Investor panel: What it takes to build a fundable biotech – with Life Science Nation Webinar Investor panel: What it takes to build a fundable biotech – with Life Science Nation Certara2026 年 8 月 6 日
Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients Publication Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…Certara2026 年 7 月 29 日
Important drug development questions that model-based meta-analysis answers Blog Important drug development questions that model-based meta-analysis answers Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…Matt Zierhut, PhD MBA2026 年 7 月 23 日
CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development Webinar CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development Hunter Stephens, PhD2026 年 7 月 17 日
Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access Webinar Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access Certara2026 年 7 月 13 日
When to conduct hepatic impairment studies and when modeling may be enough Blog When to conduct hepatic impairment studies and when modeling may be enough How to decide if a hepatic impairment study is required, choose the right study design,…Zoe Barter2026 年 7 月 13 日